Making mental health as objectively measurable as physical health.

Thymia is a London-based, online platform offering specially designed video games analyse speech patterns, facial expressions and behaviour to objectively measure mental health symptoms, starting with depression. The platform was developed as, globally, millions of people remain undiagnosed in suffering from depression. Even with the right diagnosis, it can take up to a decade for some to find the right treatment. Through her long time experience in academia and research at UCL, Emilia Molimpakis, the company's co-founder and CEO, observed that, although a multitude of tools have been developed over the past century to assess physical health, tools for assessing mental health were were mostly confined to asking questions. Thymia is brining the same evolution and objectivity of diagnostic tools to mental health, with the tracking of mental health biomarkers throught its platform. The company is backed by the likes of FORM Ventures, Calm/Storm Ventures, Kodori AG and was selected for Endeavor’s ScaleUp program in 2022. Thymia has been featured in popular media channels such as The Telegraph, BBC, and Insider.

Emilia Molimpakis dedicated her career in academia early on at UCL to decoding and understanding linguistic ellipsis. She soon realized that a massive gap existed in the way we understand and assess mental health issues, as opposed to the massive scientific advancements over time in the way we assess physical health. Through the Entrepreneur First program, Emilia, alongside her co-founder Stefano Goria, turned her research into a platform to making mental health as objectively measurable as physical health, transforming lives on a global scale.